Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
VEGF inhibitor
Pharma
Appeals court backs Regeneron's antitrust suit against Novartis
Novartis and Vetter must now defend against Regeneron's allegation that the companies conspired to delay a prefilled syringe version of Eylea.
Angus Liu
Mar 19, 2024 10:40am
FDA rejects Outlook's Avastin reformulation for eye disease
Aug 30, 2023 11:30am
Eye drug Vabysmo blasts off as Roche's biggest growth driver
Apr 26, 2023 11:07am
Roche's COVID drugs tumble $1B as new products disappoint
Oct 18, 2022 11:05am
Coherus' 3rd FDA approval comes in Lucentis copycat Cimerli
Aug 3, 2022 10:20am
Biogen launch first US biosimilar with Samsung Bioepis
Jun 2, 2022 8:00am